VIM and cancer: Vimentin is considered a cancer marker as it is overexpressed in most epithelial cancers undergoing epithelial to mesenchymal transition (EMT), and its overexpression correlates well with accelerated tumour growth, invasion, angiogenesis and poor prognosis [33–35].